HMG-CoA Reductase Inhibitors (statins)

Multum Therapeutic Class Comparison, United States, 2018

Total Prescriptions in (2018)

Drug Name	Total Prescriptions (2018)	Percent Share
Atorvastatin	112,474,024	51.5%
Simvastatin	48,007,044	22%
Rosuvastatin	24,138,061	11.1%
Pravastatin Sodium	24,022,032	11%
Lovastatin	8,769,144	4%
Pitavastatin	1,024,672	0.5%

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2008-2018. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 21.0. Read more about the ClinCalc DrugStats database.